TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | 0 | 8 | 14 | -13 | -30 | -4 |
| P | %wins | 50 | 50 | 50 | 50 | 50 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/22 16:25 | 12/8/22 | CADL | Candel Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Amello Jason | MA | O | CFO | P.m | 10 | 1.80 | 0 | 6 | New | 6 | D | ||||||||||||||
12/1/14 06:13 | 11/26/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amello Jason | MA | O | SVP,CFO, | P | 13 | 13.22 | 3 | 1 | 25 | 5 | D | -51 | -46 | -41 | 13 | -14 | -12 | -4 | -13 | -4 | -22 | -34 | -11 | ||
3/27/14 16:00 | 3/25/14 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Amello Jason | MA | O | SVP,CFO, | P | 68 | 17.00 | 30 | 4 | New | 4 | D | -20 | 3 | 13 | 19 | 49 | 8 | -48 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |